Follow
Ali Sayadmanesh
Ali Sayadmanesh
Department of Applied Cell Sciences, Tabriz University of medical Sciences & Royan Institute
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
Toll-like receptor-based strategies for cancer immunotherapy
S Pahlavanneshan, A Sayadmanesh, H Ebrahimiyan, M Basiri
Journal of Immunology Research 2021, 1-14, 2021
622021
Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity
A Sayadmanesh, F Ebrahimi, A Hajizade, M Rostamian, H Keshavarz
Iranian Biomedical Journal 17 (4), 165, 2013
232013
Inclusion body expression and refolding of recombinant bone morphogenetic protein-2
D Nasrabadi, S Rezaeiani, A Sayadmanesh, MB Eslaminejad, A Shabani
Avicenna Journal of Medical Biotechnology 10 (4), 202, 2018
142018
Cloning, expression, and functional characterization of in-house prepared human leukemia inhibitory factor
H Rassouli, S Nemati, S Rezaeiani, A Sayadmanesh, MR Gharaati, ...
Cell Journal (Yakhteh) 15 (2), 190, 2013
122013
Cloning and expression of stxB Gene from Shigella dysenteriae Gype I in E. coli Rosseta DE3
H Madanchi, H Honari, M Hesaraki, A Sayadnanesh
102012
Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
V Yekehfallah, S Pahlavanneshan, A Sayadmanesh, Z Momtahan, B Ma, ...
bioRxiv, 2022
62022
Regulatory roles of the notch signaling pathway in liver repair and regeneration: a novel therapeutic target
A Valizadeh, A Sayadmanesh, Z Asemi, F Alemi, A Mahmoodpoor, ...
Current Medicinal Chemistry 28 (41), 8608-8626, 2021
52021
Fusion of cholera toxin B subunit (ctxB) with Shigella dysenteriae type I toxin B subunit (stxB), cloning and expression that in E. coli
H Madanchi, H Honari, S Safaei, A Sayadmanesh
Journal of Fasa University of Medical Sciences 2 (3), 135-141, 2012
42012
Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer
A Sayadmanesh, V Yekehfallah, A Valizadeh, A Abedelahi, H Shafaei, ...
International Immunopharmacology 125, 111093, 2023
12023
CRISPRi-mediated knock-down of PRDM1/BLIMP1 programs central memory differentiation in ex vivo-expanded human T cells
M Azadbakht, A Sayadmanesh, N Nazer, A Ahmadi, S Hemmati, ...
BioImpacts: BI 12 (4), 337, 2022
12022
An Easy and Fast Method for Production of Chinese Hamster Ovary Cell Line Expressing and Secreting Human Recombinant Activin A
H Rassouli, A Sayadmanesh, S Rezaeiani, Z Ghezelayagh, MR Gharaati, ...
Cell Journal (Yakhteh) 22 (2), 140, 2020
12020
Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells
A Sayadmanesh, M Azadbakht, K Yari, A Abedelahi, H Shafaei, ...
Cell Journal (Yakhteh) 25 (10), 674, 2023
2023
Application of Genome-Editing Technologies for Off-the-Shelf T Cell-Based Cancer Immunotherapy
Z Hakakzadeh, V Yekehfallah, H Ebrahimiyan, A Sayadmanesh, M Basiri
Precision Medicine and Clinical OMICS 1 (1), 2021
2021
Evaluation of a New Method for Biological Activity Analysis of Recombinant Human Parathyroid Hormone-Related Protein
D Nasrabadi, S Rezaeiani, A Sayadmanesh, MR Gharaati, ...
Middle East Journal of Rehabilitation and Health 5 (2), 2018
2018
Production and functional characterization of human insulin-like growth factor 1
3* Sara Taleahmad1,#, Siamak Rezaeiani2,3,#, Ali Sayadmanesh2,3, Mostafa ...
Progress in Biological Sciences 7 (Number 1), 39-45, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–15